The current valuation score of Century Therapeutics Inc is 6.56, ranking 325 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.02, which is -84.24% below the recent high of -0.32 and -1061.55% above the recent low of -23.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.